Trading Window

GLAND PHARMA LIMITED GLAND September 30, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor 25th floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: 543245 Symbol: GLAND (ISIN: INE068V01023) Dear Sir/Madam, Sub: Closure of Trading Window This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in securities of the Company will be closed with effect from Thursday, October 01, 2026 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and half year ending on September 30, 2026. The date of the Board Meeting to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ending on September 30, 2026, will be intimated in due course. This is for your information and records. Yours truly, For Gland Pharma Limited Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer Regd. Office: Corporate Office: Survey No. 143-148, 150 & 151, Near Gandimaisamma 'X' Roads Plot No. 11 & 84, TSIIC Phase: IV D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal Pashamylaram (V), Patancheru (M), Sangareddy District Medchal-Malkajgiri District, Hyderabad 500043,Telangana, India Hyderabad 502307, Telangana, India Tel: +91-40-30510999 Fax: +91 0-30510800 Tel: +91-8455-699999 CIN: L24239TG1978PLC002276 | email: gland@glandpharma.com; investors@glandpharma.com | www.glandpharma.com